{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:28:50Z","timestamp":1791322130603,"version":"4.3.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2825,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2007.08358.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T14:51:36Z","timestamp":1279723896000},"page":"382-388","source":"Crossref","is-referenced-by-count":75,"title":["Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins"],"prefix":"10.1093","volume":"158","author":[{"given":"I.","family":"Shimanovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Grabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB1|cit1","first-page":"558","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Stanley","year":"2003"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2133.1982.tb04542.x","article-title":"Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies","volume":"106","author":"Moncada","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/archderm.1995.01690230088014","article-title":"Neonatal pemphigus foliaceus","volume":"131","author":"Walker","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/1523-1747.ep12277362","article-title":"Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB\/c mice by passive transfer","volume":"85","author":"Roscoe","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000051540","article-title":"Autoimmunity to acetylcholine receptors in pemphigus","volume":"201","author":"Grando","year":"2000","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0190-9622(82)70111-2","article-title":"Death in pemphigus","volume":"7","author":"Ahmed","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1046\/j.1365-2133.2003.05302.x","article-title":"Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus","volume":"148","author":"Schmidt","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2230.2006.02220.x","article-title":"Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption","volume":"31","author":"Shimanovich","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","article-title":"Rituximab in refractory autoimmune bullous diseases","volume":"31","author":"Schmidt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mjd.2001.116339","article-title":"Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mjd.2002.116338","article-title":"Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy","volume":"46","author":"Ahmed","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases","volume":"115","author":"Li","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2133.2004.06323.x","article-title":"Guidelines for prescribing azathioprine in dermatology","volume":"151","author":"Anstey","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000090659","article-title":"Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption","volume":"212","author":"Eming","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB19|cit19","first-page":"564","article-title":"Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus","volume":"2","author":"Schadlow","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2230.2006.02331.x","article-title":"Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin\u2019s lymphoma treated with rituximab: a third case resistant to rituximab therapy","volume":"32","author":"Hoque","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2007.07800.x","article-title":"Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients","volume":"156","author":"Goh","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.2005.06740.x","article-title":"Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab","volume":"153","author":"Schmidt","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus. A phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"15","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2007.08358.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.08358.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.08358.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T06:52:44Z","timestamp":1685688764000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/158\/2\/382\/6641185"}},"subtitle":["Immunoadsorption, rituximab and immunoglobulins in pemphigus"],"short-title":[],"issued":{"date-parts":[[2007,12,7]]},"references-count":31,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08358.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,7]]}}}